Paroxysmal atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 18 to 80 years old 2) Patients with symptomatic paroxysmal atrial fibrillation 3) Willing to participate in the clinical investigation, receive follow-up as required by the protocol and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1) Patients with previous ablation of atrial fibrillation, atrial tachycardia or atypical atrial flutter 2) Preoperative atrial tachycardia (= 30 s), atypical atrial flutter 3) Implantation of pacemaker, valve or pulmonary vein stent 4) After cardiac surgery 5) Hemorrhagic stroke within 6 months 6) Transient ischemic attack or ischemic stroke within 1 month 7) History of myocardial infarction or percutaneous transluminal coronary angioplasty within 3 months 8) Hypertrophic cardiomyopathy 9) Rheumatic heart disease 10) Patients with moderate to severe aortic valve disease, moderate to severe mitral stenosis, and severe other valve disease 11) Mental disorder or history of mental illness and inability to cooperate autonomously 12) Left atrial anteroposterior diameter > 50 mm 13) Left ventricular ejection fraction < 40% 14) Left atrial thrombosis 15) Patients with diaphragmatic paralysis 16) Lactating, pregnant or planning or potential pregnant women 17) Expected lifetime <12 months 18) Patients participating in other interventional clinical investigations 19) Not suitable for inclusion in the clinical investigation in the judgment of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Late success rate at 12 months;Incidence of major adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Acute success rate;Incidence of adverse events;Incidence of serious adverse events; | — |
Countries
China
Contacts
The Second Xiangya Hospital of Central South University